ACRUX LIMITED

6.67%

1.4¢

Market Cap $5.729M

Healthcare Drug Manufacturers - Specialty & Generic

Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is... Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is engaged in developing and commercializing a pipeline of topically applied pharmaceutical products. Its products include Lidocaine and Prilocaine Cream, USP 2.5%/2.5%, Lenzetto, Evamist, Dapsone Gel, 5% and Testosterone Topical Solution, 30 mg / 1.5 ml. Lidocaine and Prilocaine Cream USP (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on normal intact skin for local analgesia and genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia. Lenzetto (estradiol 1.53 mg/spray, transdermal spray, solution) is an estradiol spray for women which is used to treat moderate to severe hot flushes commonly associated with menopause. Testosterone Topical Solution is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.More

Neurizon's (ASX:NUZ) NUZ-001 OLE Study Demonstrates Long-Term Safety and Efficacy Signals

Latest Threads

Tag

Subject

ACR

Ann: Licensing partnership in Saudi Arabia for Dapsone 5%, Gel

04/08/25

2.8K

04/08/25

Last post mwilson25

2.8K

ACR

Ann: Quarterly Activities/Appendix 4C Cash Flow Report

31/07/25

1.6K

31/07/25

Last post jetrodder

1.6K

ACR

Ann: Change in substantial holding

25/07/25

3.8K

25/07/25

Last post Furiousgeorge

3.8K

ACR

Ann: Receipt of second advance for FY25 R&D Tax Incentive

04/07/25

667

04/07/25

Last post Socrates2

667

ACR

Ann: Notification of cessation of securities - ACR

03/07/25

197

03/07/25

Last post

ASX News

197

ACR

Ann: Application for quotation of securities - ACR

03/07/25

202

03/07/25

Last post

ASX News

202

ACR

Ann: App 3Z, Kotsanis

24/06/25

2.4K

24/06/25

Last post mwilson25

2.4K

ACR

Ann: App 3X, Warmbrunn

02/06/25

278

02/06/25

Last post

ASX News

278

See All Discussions

Timeline

Licensing partnership in Saudi Arabia for Dapsone 5%, Gel
31 Jul 09:01	Share

Quarterly Activities/Appendix 4C Cash Flow Report
30 Jul 09:03	Share

Receipt of second advance for FY25 R&D Tax Incentive
03 Jul 09:29	Share

Notification of cessation of securities - ACR
03 Jul 09:24	Share

Application for quotation of securities - ACR
03 Jul 09:23	Share

Change in substantial holding
30 Jun 14:58	Share

App 3Z, Kotsanis
02 Jun 09:05	Share

App 3X, Warmbrunn
02 Jun 09:05	Share

Appendix 3Y Brumley
23 May 09:11	Share

Application for quotation of securities - ACR
23 May 09:10	Share

Notification of cessation of securities - ACR
23 May 09:05	Share

Dapsone 7.5%, Gel launched in the United States
09 May 08:33	Share

Acrux CEO and Managing Director appointment
07 May 09:12	Share

Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 10:03	Share

Details of Share Registry address
09 Apr 12:18	Share

Appendix 3Y Dobinson
04 Apr 09:11	Share

Application for quotation of securities - ACR
04 Apr 09:08	Share

Acrux receives $1.73m advance on FY25 R&D Tax Incentive
03 Apr 09:32	Share

Attaching Options final application date 31 March 2025
07 Mar 08:18	Share

Notification of cessation of securities - ACR
06 Mar 08:18	Share

Appendix 3Y Dobinson
04 Mar 08:19	Share

Cleansing Notice
03 Mar 17:29	Share

Application for quotation of securities - ACR
03 Mar 17:29	Share

Investor Presentation February 2025
25 Feb 16:54	Share

Investor Webinar Announcement
25 Feb 16:52	Share

Appendix 4D and December 2024 Half Year Accounts
25 Feb 16:50	Share

Top20 quoted option holders and distribution schedule
19 Feb 13:53	Share

Appendix 3Y Oldham
19 Feb 12:34	Share

Appendix 3Y Kotsanis
19 Feb 12:34	Share

Appendix 3Y Brooke
19 Feb 12:31	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.4¢		Change -0.001(6.67%)		Mkt cap ! $5.729M

Open	High	Low	Value	Volume
1.4¢	1.5¢	1.4¢	$4.24K	293.2K

Buyers (Bids)

No.	Vol.	Price($)
10	1278973	1.4¢

Sellers (Offers)

Price($)	Vol.	No.
1.5¢	87310	1

View Market Depth

No.	Vol.	Price($)
10	1278973	0.014
6	759850	0.013
2	370000	0.012
2	498088	0.011
4	1270000	0.010

Price($)	Vol.	No.
0.015	87310	1
0.016	131729	3
0.017	466493	2
0.018	600861	3
0.019	146993	2

Last trade - 12.56pm 22/08/2025 (20 minute delay)

ACR (ASX) Chart

ACRUX LIMITED

Latest Threads

Listen: HotCopper Wire Podcast 021 – The inexplicable Kaili Resources rocket

Timeline

Featured News

Latest Articles

Acrux scores fourth FDA approval, Nitroglycerin Ointment moving into commercialisation

Acrux Ltd has achieved the fourth approval from the US FDA, with its Nitroglycerin Ointment 0.4%, ready for commercialisation

US FDA approves review of Acrux (ASX:ACR) nitroglycerin ointment

Acrux (ASX:ACR) has received approval from the US FDA to review a generic version of its nitroglycerin ointment at 0.4 per cent concentration.

Acrux (ASX:ACR) announces buyout of future Lenzetto royalties

Pharmaceutical company Acrux (ACR) has reached an agreement for the EUR 4.10 million (A$6.41 million) buyout of future royalties for the company's Lenzetto product.

Buyers (Bids)

Sellers (Offers)

EV Resources executes strategic MOU with Wogen, XCLR to fund and advance Los Lirios antimony project

Top Stories

Featured News